139 related articles for article (PubMed ID: 7379328)
1. Circulating immune complexes, complement and complement component levels in childhood Hodgkin's disease.
Brandeis WE; Tan C; Wang Y; Good RA; Day NK
Clin Exp Immunol; 1980 Mar; 39(3):551-61. PubMed ID: 7379328
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes in Hodgkin's disease.
Akolkar PN; Advani SH; Gothoskar BP
Neoplasma; 1983; 30(1):73-9. PubMed ID: 6835441
[TBL] [Abstract][Full Text] [Related]
3. Reaction of immune complexes with Hodgkin's disease tissue cultures: radioimmune assay and immunoferritin electron microscopy.
Long JC; Dvorak AM; Quay SC; Stamatos C; Chi SY
J Natl Cancer Inst; 1979 Apr; 62(4):787-97. PubMed ID: 372654
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complexes in sera of children with neuroblastoma: correlation with stage of disease.
Brandeis WE; Helson L; Wang Y; Good RA; Day NK
J Clin Invest; 1978 Dec; 62(6):1201-9. PubMed ID: 748375
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes in Indian childhood cirrhosis.
Kalra V; Harkiss GD; Lachmann PJ; Ghai OP
Clin Exp Immunol; 1982 Oct; 50(1):1-6. PubMed ID: 6924609
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease. Their relationship to immune function.
Spinozzi F; Velardi A; Rambotti P; Losito A; Zampi I; Cernetti C; Gerli R; Martelli MF; Grignani F
J Clin Lab Immunol; 1983 Oct; 12(2):87-92. PubMed ID: 6644793
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.
Teshima H; Wanebo H; Pinsky C; Day NK
J Clin Invest; 1977 Jun; 59(6):1134-42. PubMed ID: 325016
[TBL] [Abstract][Full Text] [Related]
8. Circulating immune complexes (CIC) in Hodgkin's disease. I. Levels and two-dimensional analysis.
Nerurkar AV; Advani SH; Gothoskar BP
Neoplasma; 1989; 36(2):199-205. PubMed ID: 2716924
[TBL] [Abstract][Full Text] [Related]
9. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
10. Influence of splenectomy on the levels of circulating immune complexes (CIC) in Hodgkin's disease (HD).
Nerurkar AV; Advani SH; Gothoskar BP
Neoplasma; 1987; 34(1):89-93. PubMed ID: 3561608
[TBL] [Abstract][Full Text] [Related]
11. Changes of serum complement and of circulating immune complexes in patients with multiple sclerosis.
Cojocaru M; Serbănescu A; Cojocaru IM
Rom J Intern Med; 1993; 31(2):131-7. PubMed ID: 8268831
[TBL] [Abstract][Full Text] [Related]
12. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
13. [Circulating immune complex and complement (C3) in a course of pulmonary tuberculosis].
Dubaniewicz A; Sztaba-Kania M
Pol Merkur Lekarski; 2002 Jun; 12(72):491-5. PubMed ID: 12362668
[TBL] [Abstract][Full Text] [Related]
14. Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.
Lew PD; Zubler R; Vaudaux P; Farquet JJ; Waldvogel FA; Lambert PH
J Clin Invest; 1979 Feb; 63(2):326-34. PubMed ID: 429556
[TBL] [Abstract][Full Text] [Related]
15. Effect of IFN-alpha on total haemolytic activity of CH50 complement system and C3, C4 levels in children with chronic hepatitis C.
Woźniakowska-Gesicka T; Wiśniewska-Ligier M; Kupś J
Med Sci Monit; 2001 May; 7 Suppl 1():202-6. PubMed ID: 12211720
[TBL] [Abstract][Full Text] [Related]
16. Complement-mediated immune complex solubilization and precipitation inhibition in sera of patients with non-Hodgkin's lymphoma.
Bányai A; Pálóczi K; Csipö I; Csongor J; Szegedi G
Haematologia (Budap); 1990; 23(2):87-95. PubMed ID: 2272539
[TBL] [Abstract][Full Text] [Related]
17. Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
Tomasević Z; Jelić S
Arch Immunol Ther Exp (Warsz); 2000; 48(3):195-200. PubMed ID: 10912625
[TBL] [Abstract][Full Text] [Related]
18. The effects of ageing on the immune response to Schistosoma haematobium and hookworm by measuring circulating immune complexes, C3, IgG, IgA and IgM levels in residents of Omi dam area of Kogi State, Nigeria.
Oyeyinka GO; Awogun IA; Akande TM; Awarun JA; Arinola OG; Salimonu LS
Afr J Med Med Sci; 2003 Sep; 32(3):263-7. PubMed ID: 15030085
[TBL] [Abstract][Full Text] [Related]
19. Correlation between immune complexes and prognostic factors in Hodgkin's disease.
Amlot PL; Pussell B; Slaney JM; Williams BD
Clin Exp Immunol; 1978 Feb; 31(2):166-73. PubMed ID: 648026
[TBL] [Abstract][Full Text] [Related]
20. Second malignant tumours in childhood Hodgkin's disease.
Jenkin D; Greenberg M; Fitzgerald A
Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
